Plain-English translation of NCT05129969 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →SMARAGD is a research platform that collects information from women with advanced ovarian or endometrial cancer as they receive treatment in German hospitals and clinics. Rather than testing a new drug, this study documents what treatments doctors actually prescribe, how well they work, and how they affect quality of life over three years. By tracking real-world treatment patterns, researchers hope to better understand what works best for patients like you.
Doctors treat advanced ovarian and endometrial cancers in many different ways, and researchers don't have clear pictures of which treatment sequences are most common or effective in everyday practice. This study aims to fill that gap by collecting real-world data so that future patients and doctors can make better-informed decisions.
You likely qualify if…
You likely don't qualify if…
You will allow the research team to collect information from your medical records as you receive cancer treatment over the next three years. This includes details about your diagnosis, all treatments you receive, any surgeries, and how you're doing—both physically and emotionally. Some participants may also be asked to complete brief quality-of-life surveys. You will not receive an experimental drug; instead, your doctors will treat you as usual, and researchers will simply document what happens.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Germany
Sponsor
iOMEDICO AG
Enrollment target
~1,975 participants
Started
November 2021
Primary completion
December 2030
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
iOMEDICO AG
Ravensburg
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.